“每日一次的upadacitinib与安慰剂在广泛非节段性白癜风成人患者中的应用：一项多中心、随机、双盲、安慰剂对照、剂量范围研究”的勘误表[ecclinicalmedicine 73(2024) 102655]。

IF 9.6 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

EClinicalMedicine Pub Date : 2025-03-19 eCollection Date: 2025-04-01 DOI:10.1016/j.eclinm.2025.103167

Thierry Passeron, Khaled Ezzedine, Lltefat Hamzavi, Nanja van Geel, Bethanee J Schlosser, Xiaoqiang Wu, Xiaohong Huang, Ahmed M Soliman, David Rosmarin, John E Harris, Heidi S Camp, Amit G Pandya

引用次数: 0

摘要

[这更正了文章DOI: 10.1016/ j.c eclinm.2024.102655.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to "Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study" [eClinicalMedicine 73(2024) 102655].

[This corrects the article DOI: 10.1016/j.eclinm.2024.102655.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

EClinicalMedicine Medicine-Medicine (all)

CiteScore

18.90

自引率

1.30%

发文量

506

审稿时长

22 days

期刊介绍： eClinicalMedicine is a gold open-access clinical journal designed to support frontline health professionals in addressing the complex and rapid health transitions affecting societies globally. The journal aims to assist practitioners in overcoming healthcare challenges across diverse communities, spanning diagnosis, treatment, prevention, and health promotion. Integrating disciplines from various specialties and life stages, it seeks to enhance health systems as fundamental institutions within societies. With a forward-thinking approach, eClinicalMedicine aims to redefine the future of healthcare.